Cargando…
Improving the solubility and bioavailability of anti-hepatitis B drug PEC via PEC–fumaric acid cocrystal
PEC is a new generation of phosphamide ester anti-hepatitis B virus drug. It is a prodrug of tenofovir and can be rapidly metabolized to tenofovir. However, its poor solubility in water (0.219 mg mL(−1) at 25 °C) has limited its oral bioavailability. In this study, we aimed to improve the solubility...
Autores principales: | Li, Long, Yin, Xian-Hong, Diao, Kai-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056957/ https://www.ncbi.nlm.nih.gov/pubmed/35517067 http://dx.doi.org/10.1039/d0ra06608g |
Ejemplares similares
-
Yet another PECS usage: A continuous PECS block for anterior shoulder surgery
por: Bossolasco, Matteo, et al.
Publicado: (2018) -
Direct PEC block: Simplified and effective alternative when US-PEC block is difficult
por: Arun, Nidhi, et al.
Publicado: (2020) -
Genomic and Temporal Trends in Canine ExPEC Reflect Those of Human ExPEC
por: Elankumaran, Paarthiphan, et al.
Publicado: (2022) -
Should we recommend PEC and when?
por: Coron, Emmanuel
Publicado: (2016) -
Effects of BDNF and PEC Nanoparticles on Osteocytes
por: Loy, Thomas Leonhard, et al.
Publicado: (2020)